Health systems worldwide are expanding newborn screening programs to detect rare genetic and metabolic disorders earlier. Kansas, Florida, and Korea are launching new tests for conditions like GAMT deficiency and rare liver disease, while the WHO pushes for global scale-up of screening capabilities.
·Kansas expands newborn screening to include GAMT deficiency and rare seizure-linked genetic disorder
·Florida pilots new screening program specifically for rare liver disease in newborns
·Korea introduces first automated newborn screening platform to increase testing capacity
·WHO calls for worldwide scaling of newborn screening to improve early detection and care outcomes
·Parents increasingly face complex decisions about what genomic information to obtain through expanded screening
drawn from Hays Post, World Health Organization (WHO), Nature, WKMG · updated 5h ago